TY  - JOUR
AU  - Santander Ballestín, Sonia
AU  - Abadía Labena, María
AU  - Avedillo-Salas, Ana
AU  - Marco Continente, Cristina
AU  - Arribas Blázquez, Marina
AU  - Luesma Bartolomé, María José
PY  - 2025
DO  - 10.3390/cancers17050760
SN  - 2072-6694
UR  - https://hdl.handle.net/20.500.14352/118832
T2  - Cancers
AB  - Background and Objectives: Breast cancer is the most common malignant neoplasm worldwide and the most prevalent one among women. It represents the leading cause of cancer-related death among females. Cyclin-dependent kinase 4 and 6 inhibitors disrupt...
AB  - Simple Summary:Breast cancer is the most common malignant neoplasm worldwide and the most prevalent one among women. Cyclin-dependent kinase 4 and 6 inhibitors have become a novel form of adjuvant therapy for the treatment of advanced or metastatic...
LA  - eng
M2  - 1
PB  - MDPI
KW  - Breast cancer
KW  - Cyclin-dependent kinase 4 and 6 inhibitors
KW  - Endocrine therapy
KW  - Hormone therapy
KW  - Metastasis
TI  - Advances in CDK4 and 6 Inhibitors: Transforming Breast Cancer Treatment.
TY  - journal article
VL  - 17
ER  -